The use of free versus in situ right internal mammary artery in coronary artery bypass grafting.

bilateral internal mammary artery coronary artery bypass grafting major adverse cardiac and cerebrovascular event mortality right internal mammary artery

Journal

Journal of cardiac surgery
ISSN: 1540-8191
Titre abrégé: J Card Surg
Pays: United States
ID NLM: 8908809

Informations de publication

Date de publication:
Oct 2021
Historique:
revised: 03 06 2021
received: 20 04 2021
accepted: 07 06 2021
pubmed: 10 7 2021
medline: 14 9 2021
entrez: 9 7 2021
Statut: ppublish

Résumé

Coronary artery bypass grafting (CABG) continues to be the most commonly performed cardiac surgical procedure in the world. The use of multiarterial grafting may confer a long-term survival benefit over the use of vein grafts. However, there is a paucity of data comparing the use of in situ versus free right internal mammary artery (RIMA) in isolated CABG. Patients that underwent isolated CABG between 2010 and 2018 where RIMA was used in addition to a left internal mammary artery graft. Patients with prior cardiac surgery or percutaneous coronary intervention were excluded. Propensity matching was used for subanalysis. Mortality and major adverse cardiac and cerebrovascular events (MACCE) were analyzed with Kaplan-Meier survival curves and Cox multivariable regression. Heart failure-specific readmissions were assessed with cumulative incidence curves with Fine and Gray competing risk regression. A total of 667 patients underwent isolated CABG. Of those, 422 had free RIMA and 245 had in situ RIMA utilized. Mortality was similar between cohorts (p = 0.199) with 5-year mortality rates of 6.6% (free) and 4.1% (in situ). MACCE was similar between cohorts, with 5-year event rates of 33.6% and 33.9% (p = 0.99). RIMA style was not a significant predictor of any outcome. There was no difference in long-term mortality, complications, MACCE, or heart failure readmissions when comparing a contemporary cohort of patients undergoing isolated CABG utilizing RIMA as a conduit. These data may allow surgeons to consider using RIMA either as an in situ or a free conduit.

Identifiants

pubmed: 34242433
doi: 10.1111/jocs.15797
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3631-3638

Informations de copyright

© 2021 Wiley Periodicals LLC.

Références

D'Agostino RS, Jacobs JP, Badhwar V, et al. The society of thoracic surgeons adult cardiac surgery database: 2018 update on outcomes and quality. Ann Thorac Surg. 2018;105(1):15-23.
Goyal A, Kahlon P, Jain D, et al. Trend in prevalence of coronary artery disease and risk factors over two decades in rural Punjab. Heart Asia. 2017;9(2):e010938.
Koopman C, Vaartjes I, Blokstra A, et al. Trends in risk factors for coronary heart disease in the Netherlands. BMC Public Health. 2016;16(1):835.
Virani SS, Alonso A, Benjamin EJ, et al. Heart disease and stroke statistics-2020 update: a report from the American Heart Association. Circulation. 2020;141(9):e139-e596.
Bianco V, Kilic A, Gleason TG, et al. Midterm outcomes for isolated coronary artery bypass grafting in octogenarians. Ann Thorac Surg. 2020;109(4):1184-1193.
Mulukutla SR, Gleason TG, Sharbaugh M, et al. Coronary bypass versus percutaneous revascularization in multivessel coronary artery disease. Ann Thorac Surg. 2019;108(2):474-480.
Chan PG, Sultan I, Gleason TG, et al. Contemporary outcomes of coronary artery bypass grafting in obese patients. J Card Surg. 2020;35(3):549-556.
Shi WY, Hayward PA, Tatoulis J, et al. Are all forms of total arterial revascularization equal? A comparison of single versus bilateral internal thoracic artery grafting strategies. J Thorac Cardiovasc Surg. 2015;150(6):1526-1533.
Buxton BF, Shi WY, Tatoulis J, Fuller JA, Rosalion A, Hayward PA. Total arterial revascularization with internal thoracic and radial artery grafts in triple-vessel coronary artery disease is associated with improved survival. J Thorac Cardiovasc Surg. 2014;148(4):1238-1243.
Sundt TM III, Barner HB, Camillo CJ, Gay WA Jr. Total arterial revascularization with an internal thoracic artery and radial artery T graft. Ann Thorac Surg. 1999;68(2):399-404.
Rocha RV, Tam DY, Karkhanis R, et al. Long-term outcomes associated with total arterial revascularization vs. non-total arterial revascularization. JAMA Cardiol. 2020;5(5):507-514.
Raja SG, Benedetto U, Jothidasan A, et al. Right internal mammary artery versus radial artery as second arterial conduit in coronary artery bypass grafting: a case-control study of 1526 patients. Int J Surg. 2015;16(pt B):183-189.
Hata M, Yoshitake I, Wakui S, et al. Long-term patency rate for radial artery vs. Saphenous vein grafts using same-patient materials. Circ J. 2011;75(6):1373-1377.
Royse A, Pamment W, Pawanis Z, et al. Patency of conduits in patients who received internal mammary artery, radial artery and saphenous vein grafts. BMC Cardiovasc Disord. 2020;20(1):148.
Iribarn A, Schmoker JD, Malenka DJ, et al. Does use of bilateral internal mammary artery grafting reduce long-term risk of repeat coronary revascularization? Circulation. 2017;136(18):1676-1685.
Kurlansky PA, Traad EA, Dorman MJ, Galbut DL, Ebra G. Bilateral versus single internal mammary artery grafting in the elderly: long-term survival benefit. Ann Thorac Surg. 2015;100(4):1374-1381.
Taggart DP, Benedetto U, Gerry S, et al. Bilateral versus single internal-thoracic-artery grafts at 10 years. N Engl J Med. 2019;380(5):437-446.
Iribarne A, Goodney PP, Flores AM, et al. National trends and geographic variation in bilateral internal mammary artery use in the United States. Ann Thorac Surg. 2017;104(6):1902-1907.
Kim LK, Looser P, Swaminathan RV, et al. Outcomes in patients undergoing coronary artery bypass graft surgery in the united states based on hospital volume, 2007 to 2011. J Thorac Cardiovasc Surg. 2016;151(6):1686-1692.
Bianco V, Kilic A, Gleason TG, et al. Timing of coronary artery bypass grafting after acute myocardial infarction may not influence mortality and readmissions. J Thorac Cardiovasc Surg. 2019;161:2056-2064.
Appoo J, Norris C, Merali S, et al. Long-term outcome of isolated coronary artery bypass surgery in patients with severe left ventricular dysfunction. Circulation. 2004;110(11 suppl 1):II-13-II-17.
Seese L, Sultan I, Wang Y, Navid F, Kilic A. Off-pump coronary artery bypass surgery lacks a longitudinal survival advantage in patients with left ventricular dysfunction. J Card Surg. 2020;35(8):1793-1801.
Bianco V, Kilic A, Gleason TG, et al. Long-term outcomes after reoperative coronary artery bypass grafting. Ann Thorac Surg. 2021;111(1):150-158.
Zhu YY, Seco M, Harris SR, et al. Bilateral versus single internal mammary artery use in coronary artery bypass grafting: a propensity-matched analysis. Heart Lung Circ. 2019;28(5):807-813.
Pevni D, Aizer Z, Mohr R, et al. Are two internal thoracic grafts better than one in patients with chronic obstructive lung disease? Analysis of 387 cases between 1996-2011. PLOS One. 2018;13(8):e0201227.
Yi G, Shine B, Rehman SM, Altman DG, Taggart DP. Effect of bilateral internal mammary artery grafts on long-term survival: a meta-analysis approach. Circulation. 2014;130(7):539-545.
Saran N, Locker C, Said SM, et al. Current trends in bilateral internal thoracic artery use for coronary revascularization: extending benefit to high-risk patients. J Thorac Cardiovasc Surg. 2018;155(6):2331-2343.
Di Mauroi M, Iacò AL, Allam A, et al. Bilateral internal mammary artery grafting: in situ versus Y-graft. Similar 20-year outcome. Eur J Cardiothorac Surg. 2016;50(4):729-734.
Marzouk M, Kalavrouziotis D, Grazioli V, et al. Long-term outcome of the in situ versus free internal thoracic artery as the second arterial graft. J Thorac Cardiovasc Surg. 2020
Paterson HS, Naidoo R, Byth K, Chen C, Denniss AR. Full myocardial revascularization with bilateral internal mammary artery Y grafts. Ann Cardiothorac Surg. 2013;2(4):444-452.
Ruttmann E, Fischler N, Sakic A, et al. Second internal thoracic artery versus radial artery in coronary artery bypass grafting: a long-term, propensity score-matched follow-up study. Circulation. 2011;124(12):1321-1329.
Rosenblum JM, Harskamp RE, Hoedemaker N, Walker P, Liberman HA, de Winter RJ, Vassiliades TA, Puskas JD, Halkos ME. Hybrid coronary revascularization versus coronary artery bypass surgery with bilateral or single internal mammary artery grafts. The Journal of Thoracic and Cardiovascular Surgery. 2016;151 (4):1081-1089. https://doi.org/10.1016/j.jtcvs.2015.10.061
Falk V. Coronary bypass grafting with bilateral internal thoracic arteries. Heart. 2013;99(12):821.
Schoell T, Genser L, Clément M, et al. Bilateral internal thoracic artery grafting in women: a word of caution. Heart Surg Forum. 2019;22(1):E045-E049.
Saraiva FA, Girerd N, Cerqueira RJ, et al. Survival after bilateral internal mammary artery in coronary artery bypass grafting: Are women at risk? Int J Cardiol. 2018;270:89-95.
Sellers SL, Holmes KR, Leipsic JA. Sex differences in cardiovascular medicine: bilateral internal mammary artery CABG. Int J Cardiol. 2019;288:53-54.

Auteurs

Edgar Aranda-Michel (E)

Division of Cardiac Surgery, Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Derek Serna-Gallegos (D)

Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.

Forozan Navid (F)

Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.

Arman Kilic (A)

Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.

Abraham A Williams (AA)

Division of Cardiac Surgery, Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Ricardo Garcia (R)

Division of Cardiac Surgery, Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Valentino Bianco (V)

Division of Cardiac Surgery, Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

James A Brown (JA)

Division of Cardiac Surgery, Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Ibrahim Sultan (I)

Division of Cardiac Surgery, Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH